Internal Medicine, Endocrinology, Diabetes, & Metabolism · San Francisco, CA
NPI
1972571255
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
3
Medicare group memberships
Hospitals
2
Hospital affiliations
400 Parnassus Ave
San Francisco, CA, 94143
Phone (415) 353-2350
Groups this clinician bills Medicare through
Medicare paid, 2024
$103K
1,699 services
Medicare patients, 2024
396
Average age 72
Drug cost, 2024
$1.0M
2,890 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Umesh Masharani was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 593 times for 288 patients. In total Umesh Masharani billed 1,699 services in 20 codes, and Medicare paid $103K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-08-04.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 593 | 288 | $14.58 | $8,649 |
| 99215 Office E&M - Established | Facility | 433 | 250 | $118.44 | $51K |
| 95251 Test - Miscellaneous | Facility | 214 | 104 | $29.21 | $6,252 |
| 99214 Office E&M - Established | Facility | 191 | 114 | $82.52 | $16K |
| 99232 Hospital E&M - Subsequent | Facility | 43 | 23 | $62.84 | $2,702 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 41 | 22 | $26.57 | $1,089 |
| 99205 Office E&M - New | Facility | 37 | 37 | $139.73 | $5,170 |
| 99451 E&M - Miscellaneous | Facility | 33 | 32 | $31.32 | $1,034 |
| 99233 Hospital E&M - Subsequent | Facility | 21 | 18 | $103.51 | $2,174 |
| 99222 Hospital E&M - Initial | Facility | 17 | 17 | $99.02 | $1,683 |
| 99443 Telephone Services | Facility | 14 | 13 | $80.89 | $1,132 |
By year: 2022 $80K for 956 services; 2023 $90K for 1,024 services; 2024 $103K for 1,699 services.
Medicare prescription drug claims, 2024
In 2024, the drug Umesh Masharani prescribed most often to Medicare patients was Levothyroxine Sodium, with 328 prescriptions and refills. In total Umesh Masharani wrote 2,890 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 328 | 889 | 88 | $4,814 |
| Ozempic Semaglutide | 203 | 327 | 47 | $301K |
| Metformin Hcl Generic | 160 | 436 | 49 | $1,642 |
| Ultra-Fine Short Pen Needle Pen Needle, Diabetic | 121 | 287 | 53 | $18K |
| Jardiance Empagliflozin | 113 | 251 | 28 | $138K |
| Rosuvastatin Calcium Generic | 112 | 323 | 38 | $3,311 |
| Humalog Kwikpen U-100 Insulin Lispro | 89 | 147 | 30 | $29K |
| Glipizide Generic | 89 | 230 | 24 | $1,128 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 87 | 159 | 34 | $12K |
| Atorvastatin Calcium Generic | 81 | 240 | 30 | $933 |
| Methimazole Generic | 79 | 193 | 21 | $957 |
| Synthroid Levothyroxine Sodium | 57 | 171 | 15 | $4,341 |
| Metformin Hcl Er Metformin Hcl | 56 | 146 | 23 | $753 |
| Ezetimibe Generic | 53 | 157 | 19 | $1,647 |
| Tresiba Flextouch U-100 Insulin Degludec | 48 | 87 | 16 | $33K |
Brand drugs: 1,227 claims; generic drugs: 1,418 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Umesh Masharani were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.